diabetestalk.net

Kid On Cutting Edge In Diabetes Trial

Kid on cutting edge in diabetes trial

Kid on cutting edge in diabetes trial


Jackson 6-year-old tests new insulin pump for Type 1 youngsters.
Cashs mom, Mills Halpin, encourages him to eat more chicken at dinner with his brother in late June. Getting the right amount of carbs can be a guessing game because sometimes he doesnt eat everything, she said.
Cash Halpin shovels the last bite of rice into his mouth and asks for another serving.
I ate all the carbs, he proudly announces, mouth still full.
Yeah, says his mother, Mills Halpin, who rolls her eyes at her 6-year-old son. Eat some protein.
His father, Mike Halpin, is beside him on an opened laptop, checking the latest data available from Cashs insulin pump. The boy is part of a clinical trial testing the Medtronic MiniMed670G, a system capable of continuously monitoring his glucose levels and making microadjustments to keep them consistent throughout the day.
Cash is in the youngest group of participants to be tested, ages 2 to 6. The same Medtronic model was approved by the U.S. Food and Drug Administration last fall for ages 14 and up.
Mike Halpin administers about a unit of insulin, a tiny bubble of hormone to handle the approximately 35 grams of carbs Cash is consuming for dinner. Manual adjustments are still required at mealtimes, but the new system offers his parents a little reprieve, something they havent experienced since hewas diagnosed three years ago.
Halpin has to wear an insulin pump at all times, which monitors his levels and injects insulin when needed through an infusion port under his skin.
With this new system, if they are off a little you just cant be exact all the Continue reading

Rate this article
Total 1 ratings
Newly published research provides new insight into how diabetes leads to retinopathy

Newly published research provides new insight into how diabetes leads to retinopathy


Newly published research provides new insight into how diabetes leads to retinopathy
December 7, 2017 by Kathy Keatley Garvey, UC Davis
Diabetic retinopathy is the most common diabetic eye disease and a leading cause of adult blindness. Chronically high blood sugar from diabetes damages the tiny blood vessels in the retina, leading to diabetic retinopathy, according to the National Eye Institute of the National Institutes of Health. Credit: Kathy Keatley Garvey
An international team of scientists led by Professor Ingrid Fleming of Goethe University, Frankfurt, Germany, and including Professor Bruce Hammock of the University of California, Davis, provides new insight into the mechanism by which diabetes leads to retinopathy and often to blindness.
An inhibitor to the enzyme, soluble epoxide hydrolase (sEH), discovered in the Hammock lab, prevented the eye disease in diabetic mice, Fleming said.
The paper, "Inhibition of Soluble Epoxide Hydrolase Prevents Diabetic Retinopathy," involving six years of research and 22 scientists, is published today (Dec. 6) in the journal Nature.
"This has been a long but exciting project where Dr. Fleming's team used tools developed to study the biology of fatty acid epoxides to probe the fundamental mechanism of diabetic retinopathy," said co-author Hammock, a distinguished professor of entomology who holds a joint appointment with the UC Davis Department of Entomology and Nematology and the UC Davis Comprehensive Cancer Center "This work has targeted many possible sites for intervention that could preserve vision, and one such target Continue reading

Now Monitor Diabetes With a Pain-Free Skin Patch: 5 Foods Which May Help Too

Now Monitor Diabetes With a Pain-Free Skin Patch: 5 Foods Which May Help Too


Now Monitor Diabetes With a Pain-Free Skin Patch: 5 Foods Which May Help Too
Researchers have developed a pain-free skin patch containing dissolvable compounds that responds to blood chemistry to manage glucose automatically.
Food | NDTV Food Desk | Updated: December 27, 2017 13:35 IST
Here's a news that will make all diabetics take a leap of joy. Researchers have developed a pain-free skin patch containing dissolvable compounds that responds to blood chemistry to manage glucose automatically.
Diabetes is a disorder in which which the body's ability to produce or respond to the hormone insulin is impaired, resulting in abnormal metabolism of carbohydrates and spike in blood sugar(glucose) levels. Diabetes is one of the leading global health concerns of the current times. Global incidence of all types of diabetes is about 285 million people, of which 90 per cent have Type-2 diabetes.
A finger prick before mealtimes and maybe an insulin injection is an uncomfortable but necessary routine for people with type 2 diabetes for their ongoing vigilance over the amount of sugar. Bit according to a latest study published online in the journal Nature Communication, researchers have found a biochemical formula of mineralised compounds in the patch that responds to sugar levels for days at a time.
The study conducted over a group of mice, the researchers identified that the biochemically formulated patch of dissolvable microneedles can make the management of Type-2 diabetes much easier.
"This experimental approach could be a way to take advantage of the fact that persons with T Continue reading

Second Thought – The Often-Forgotten Challenges of Diabetes

Second Thought – The Often-Forgotten Challenges of Diabetes

By Jane Yardley
November is Diabetes Awareness month, a time of year where we recognize the staggering number of individuals affected by diabetes in Canada and worldwide. In Canada alone, there were over 3 million people with diagnosed diabetes in 2015. Approximately 90 to 95% of these people will have type 2 diabetes, a condition that is managed initially with diet and exercise, and ultimately with medication. The remaining 5 to 10% will have type 1 diabetes, for which there is no prevention, there is no cure, and survival requires a careful balance of food intake and insulin dosage.
Canada has one of the highest rates of type 1 diabetes in the world, yet the public is not as aware of the disease as they are with cancer or cardiovascular disease. Type 1 diabetes develops when the immune system attacks and destroys the insulin-producing cells of the pancreas. Insulin acts as the key that unlocks cells in the muscles, fatty tissues and liver to allow glucose (the most common form of sugar in the body) to be taken in for storage, or burned for energy. Without insulin, glucose builds up in the blood, and the body’s tissues slowly starve. Upon diagnosis, people with type 1 diabetes are relegated to a life of counting carbohydrates (and considering carbohydrate quality) at every meal, and taking insulin (either with a needle or with an insulin pump where a small tube sits under the skin) multiple times per day when blood glucose levels creep up.
They also live with the constant fear that their glucose levels will drop too low. This phenomenon, termed hypoglycemia, can have imm Continue reading

Cooking With Herbs and Spices

Cooking With Herbs and Spices


Herbs and spices are a healthy cooks best friend. They are excellent for enhancing the flavor of food without the addition of extra fat, sugar, or salt. But herbs and spices have other benefits, as well: They exhibit antimicrobial (germ-killing) properties, act as antioxidants , and may help prevent or decrease the spread of cancer. For centuries, they have been used for medicinal purposes in addition to food flavoring and preservation. The use of herbs, which typically come from the leaves of plants, has been traced back to the BC era. Spices, which come from the bark, fruit, stems, roots, buds, berries, or seeds of plants, started to be used widely around the second century AD. Centuries ago, people thought that herbs and spices had certain properties that benefited health. Today, scientists have uncovered just how healthful many herbs and spices are.
In one study, researchers at the U.S. Department of Agriculture examined the antioxidant activity (the ability to protect cells against the effects of free radicals, unstable molecules that result from the breakdown of food, exposure to pollutants, or UV light) of fresh herbs grown in a garden at the Agricultural Research Service. They found that each of the herbs tested had greater antioxidant activity by weight than berries, fruits, or vegetables. According to this study, just one tablespoon of fresh oregano has the same antioxidant power as a medium-size apple. How do other herbs stack up? Three tablespoons of dill, 4 1/2 tablespoons of thyme, 7 tablespoons of sage, and 8 tablespoons of parsley all have the antioxidant Continue reading

No more pages to load

Popular Articles

  • Researchers Are Putting This Potential Diabetes Cure to the Test in a 3-Year-Long Trial

    There just might be some very exciting news on the horizon for people with diabetes! If you’ve suffer from the condition, you’ve likely been warned of the risk of high blood pressure and heart disease. And if you have high blood pressure, you’ve probably heard of Verapamil, a rather common blood pressure medication. Well, it’s recently served another purpose: researchers have recently used ...

  • Xultophy® Reported a Better Option than Basal-Bolus Insulin Therapy to Manage Type 2 Diabetes by Participants in the DUAL VII Clinical Trial

    Abu Dhabi, Uae (ots/PRNewswire) - Once-daily Xultophy® (insulin degludec/liraglutide) was a better option to manage diabetes compared to multiple daily injections of insulin (basal-bolus regimen). This was reported by people with type 2 diabetes whose blood sugar was not controlled on insulin glargine U100 with metformin, and who completed quality-of-life questionnaires as part of the DUAL VII cl ...

  • First patient in diabetes trial no longer needs insulin therapy

    MIAMI, Sept. 10 (UPI) -- The first patient to receive therapeutic delivery of islet cells in a new diabetes study no longer needs insulin therapy to control type 1 diabetes, according to doctors at the University of Miami's Diabetes Research Institute. The patient, Wendy Peacock, 43, has been giving herself insulin injections to control diabetes since she was diagnosed with the condition at age 17 ...

  • Pouch of stem cells implanted in trial to cure type 1 diabetes

    Viacyte, privately-held, leading regenerative medicine company, announced today that the first patients have been implanted with the PEC-Direct™ product candidate, a novel islet cell replacement therapy in development as a functional cure for patients with type 1 diabetes who are at high risk for acute life-threatening complications. The first implant procedures of the clinical trial took place ...

  • London trial to aggressively treat diabetes expanding

    Aggressive treatment for Londoners with Type 2 diabetes has proven so popular, Lawson Health Research Institute will open up enrolment in a study for a third time since 2015. Doctors usually start treating diabetics with a single medication, and only add other drugs and insulin if the disease worsens. That wait-and-see approach has been turned on its head in a study in which doctors treat patients ...

  • A Type 1 Diabetes Pill? Newest Sotagliflozin Trial Results

    Research reveals improved A1c and weight loss benefits for people with type 1 diabetes on sotagliflozin, but a slightly increased risk of DKA The American Diabetes Association’s (ADA) 77th Scientific Session in June convened key leaders in diabetes research to share findings on the latest drug developments. At the conference, Lexicon Pharmaceuticals presented full results from three major trials ...

  • New clinical trial could offer a functional cure for people with type 1 diabetes

    New clinical trial could offer a functional cure for people with type 1 diabetes New clinical trial could offer a functional cure for people with type 1 diabetes The ViaCyte trial is being run at three sites in North America, including University of Minnesota Health. Greg Romero (right) has to live with his type 1 diabetes all day, every day. But a new clinical trial offered through Universit ...

  • Mass. General Hospital launches phase II trial of BCG vaccine to reverse type 1 diabetes

    Mass. General Hospital launches phase II trial of BCG vaccine to reverse type 1 diabetes FDA approval of trial testing generic vaccine announced at ADA Scientific Sessions A phase II clinical trial testing the ability of the generic vaccine bacillus Calmette-Gurin (BCG) to reverse advanced type 1 diabetes has received approval from the U.S. Food and Drug Administration (FDA). The approval of t ...

  • Diabetes Care Management Teams Did Not Reduce Utilization When Compared With Traditional Care: A Randomized Cluster Trial

    Diabetes Care Management Teams Did Not Reduce Utilization When Compared With Traditional Care: A Randomized Cluster Trial Professor of Medicine (Adjunct), Stanford School of Medicine, (Retired); Director, Chronic Care Program, Santa Clara Valley Medical Center, (Retired) Purpose: Health services research evaluates redesign models for primary care. Care management is one alternative. Evaluation ...

Related Articles